In the race to better understand cancer, Madison's Promega Corp. has thousands of genomic and cellular analysis products on the market. The company says its newest bioluminescent assays provide researchers with the greatest sensitivity for caspase-2 and -6. In plain English, that means that scientists...
The search for a higher quality HPV testing solution continues to be the focus of a patent infringement suit involving Madison's Third Wave Technologies and Digene Corp. Third Wave has lost the latest round of legal outcomes, but still claims an advantage in the wider...
Madison's Promega Corp. has entered into an agreement with the California-based MultiSpan to combine their technologies and improve the testing of drug candidates. The companies hope to develop solutions that will reduce assay development time on certain drugs from months to days. ...
Madison Development Corp. has announced a second round of funding for its Venture Debt Program, bringing the fund's total capital to $4.274 million. The fund was established to help technology businesses, and among its first-round borrowers were NeoClone, GenTel Biosciences, and Networked Insights....
The Madison bio-pharmaceutical company Centrose, which is trying to advance its CarboConnect platform for drug discovery, has received another federal grant, this one worth $190,000. The latest funding comes from the National Institute of General Medical Services. ...
The Madison-based radiopharmaceutical firm Cellectar has raised $13 million in a private offering led by Venture Investors. The funds will be used for a Phase 1 clinical trial that could validate the company's lead oncology candidate, a cancer-fighting molecule that has shown promise in preclinical...
The Wisconsin Alumni Research Foundation, the licensing arm of the University of Wisconsin-Madison, has announced a licensing agreement with the California firm BioTime. The agreement involves patents and patent applications related to human embryonic stem cell technology created by professor James Thomson. ...
Madison, Wis. — Third Wave Technologies has announced that distributors in Spain, Portugal, and Italy have agreed to distribute the firm's human papillomavirus screening product. The product, which is used for routine screening for cervical cancer, detects 14 types of HPV....
Like many other aspects of personal finance, the decision to sell your business will depend largely on tax implications. As columnist and attorney Joe Boucher explains in this edition of Early Stage, business owners face a choice between selling their ownership interests or selling their...
Following the news that scientists at the University of Wisconsin-Madison and in Japan can turn human skin cells into stem cells, the WiCell Research Institute has indicated to the National Institutes of Health that it would like to house and distribute lines created with the...